Back

Correlation of ELISA based with random access serologic immunoassays for identifying adaptive immune response to SARS-CoV-2

2020-07-08 pathology Title + abstract only
View on medRxiv
Show abstract

Public health emergency of SARS-CoV-2 has facilitated diagnostic testing as a related medical countermeasure against COVID-19 outbreak. Numerous serologic antibody tests have become available through an expedited federal emergency use only process. This paper highlights the analytical characteristic of an ELISA based assay by AnshLabs and three random access immunoassay (RAIA) by DiaSorin, Roche, and Abbott that have been approved for emergency use authorization (EUA), at a tertiary academic cen...

Predicted journal destinations